MedTrace Logo

the Influence of Sleep Improvement Through Different Methods on Patients in ICU

NCT03480789 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2018-03-29

No results posted yet for this study

Summary

In the research, we enroll 120 postoperative patients in the ICU and they will be assigned to four group: the eye patch group, the Dexmedetomidine(DEX) group, the eye patch+DEX group and the usual group. The sleep quality would be evaluated by the EEG monitor and the metabolic level, the inflammation and nutrition status would be detected.

Conditions

  • Metabolic Problems
  • Sleep

Interventions

DRUG

Dexmedetomidine

given dexmedetomidine to meet RASS -1 from 22:00 to 6:00 of the next day

DEVICE

eye patch

wearing the eye patch from 22:00 to 6:00 of the next day

Sponsors & Collaborators

  • Chinese Medical Association

    lead NETWORK

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-05
Primary Completion
2018-06-30
Completion
2018-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03480789 on ClinicalTrials.gov